ArriVent BioPharma Reports First Quarter 2026 Financial Results

Go back to ArriVent BioPharma Reports First Quarter 2026 Financial Results
(NASDAQ: AVBP) Delayed: 31.01 +0.40 (1.31%)
Previous Close $30.61    52 Week High
Open $30.61    52 Week Low
Day High $31.51    P/E N/A 
Day Low $30.08    EPS
Volume 181,581